Total Niacin
94/100
This product looks safe
- Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
- 83% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
Other Combinations
Product Type
83%
Evidence Coverage
Supplement Facts — Evidence Check
100 mg
(500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 2.9× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
5 mg
(250% DV)
📊 3.8× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
100 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
25 mg
✅ 1.8× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
Gamma Oryzanol
25 mg
50 mg
📊 Market median: 300.0mg (122 products)
📚 22 studies (Tier A: 0, B: 7)
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Sugar Free
Product Information
📋 Directions for Use
Directions for use: One tablet daily, or as directed.
⚠️ Warnings & Precautions
SOME PEOPLE MAY EXPERIENCE SOME FLUSHING. DO NOT TAKE ON AN EMPTY STOMACH. CONTACT YOUR DOCTOR IF YOU HAVE ANY QUESTIONS.
KEEP OUT OF REACH OF CHILDREN.
TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.
🧪 Formulation Notes
Contains no starch, salt, sugar, corn, yeast, soy, gluten, or preservatives.
Additional Information
Product # 2745
Manufactured under strict GMP and USP guidelines.
"When You Want The Best"
MFG05/2009
FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY.
Store in cool, dry place.
Product Details
DSLD Entry Date
2013-12-24
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Nutri-West
DSLD ID
28631
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100